Sell Alert

In July, we recommended QVC’s 4.375% bond maturing September 1, 2028, when it was trading for around $430. Today, we are recommending selling the bond.  We have noticed a recent turn in the distressed-debt market. Until recently, investors tended to look beyond any hiccups in a company’s performance to focus on the longer-term outlook. In

In the Distressed Investing April 10 report, “Car Talk,” we recommended buying Cerence AI’s 1.5% convertible bond maturing July 1, 2028. Today, we recommend selling the bond. At the time of the recommendation, the bond was priced at $692, which equated to annual yield of 13.6%. We indicated that we thought it extremely unlikely that

We are recommending investors sell their position in offshore driller Sable Offshore (NYSE: SOC), which we recommended in December 2024 as part of the “Trump’s Secret Stocks” basket in The Big Secret On Wall Street portfolio. 

In the May 8 Distressed Investing report, “Cracking the Code,” we recommended the combined $1,000 purchase of one Green Plains 2.25% convertible bond, then trading at $774, and shares of Green Plain stock (Nasdaq: GPRE), then trading at $3.66. At the time this equated to one bond and 61.7 shares. Recently we recommended selling the

Shares of the Tech Frontiers July recommendation, Prime Medicine (Nasdaq: PRME), are trading at around $6.37 today, a gain of over 100% from our entry price of $3.07 three months ago. As a result, we recommend selling half your position. Prime is making terrific progress advancing its gene-editing platform and we have many reasons for